CONSTA in Polynesian Subjects

An observational study of the impact of long-acting risperidone microspheres on the symptom severity and functional recovery in Maori and Pacific people with schizophrenia and related psychotic disorders

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12605000384651

Acronym

CIPS

Enrollment

Registered

2005-09-13

Start date

2006-08-09

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Risperdal Consta injections as determined by the treating psychiatrist for up to two years.

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

Primary disgnosis of schizophreniaUnder care of an ethnic specific service.

Exclusion criteria

Unable to give consent.Risperidone prescription contra-indicated.

Outcome results